Aerosolized ribavirin: the most expensive drug for pneumonia.
Publication
, Journal Article
Chemaly, RF; Aitken, SL; Wolfe, CR; Jain, R; Boeckh, MJ
Published in: Transpl Infect Dis
August 2016
Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increases, may now cost more than the transplant procedure itself.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Transpl Infect Dis
DOI
EISSN
1399-3062
Publication Date
August 2016
Volume
18
Issue
4
Start / End Page
634 / 636
Location
Denmark
Related Subject Headings
- Treatment Outcome
- Surgery
- Ribavirin
- Respiratory Syncytial Virus Infections
- Pneumonia, Viral
- Orphan Drug Production
- Infant
- Humans
- Hematopoietic Stem Cell Transplantation
- Health Policy
Citation
APA
Chicago
ICMJE
MLA
NLM
Chemaly, R. F., Aitken, S. L., Wolfe, C. R., Jain, R., & Boeckh, M. J. (2016). Aerosolized ribavirin: the most expensive drug for pneumonia. Transpl Infect Dis, 18(4), 634–636. https://doi.org/10.1111/tid.12551
Chemaly, R. F., S. L. Aitken, C. R. Wolfe, R. Jain, and M. J. Boeckh. “Aerosolized ribavirin: the most expensive drug for pneumonia.” Transpl Infect Dis 18, no. 4 (August 2016): 634–36. https://doi.org/10.1111/tid.12551.
Chemaly RF, Aitken SL, Wolfe CR, Jain R, Boeckh MJ. Aerosolized ribavirin: the most expensive drug for pneumonia. Transpl Infect Dis. 2016 Aug;18(4):634–6.
Chemaly, R. F., et al. “Aerosolized ribavirin: the most expensive drug for pneumonia.” Transpl Infect Dis, vol. 18, no. 4, Aug. 2016, pp. 634–36. Pubmed, doi:10.1111/tid.12551.
Chemaly RF, Aitken SL, Wolfe CR, Jain R, Boeckh MJ. Aerosolized ribavirin: the most expensive drug for pneumonia. Transpl Infect Dis. 2016 Aug;18(4):634–636.
Published In
Transpl Infect Dis
DOI
EISSN
1399-3062
Publication Date
August 2016
Volume
18
Issue
4
Start / End Page
634 / 636
Location
Denmark
Related Subject Headings
- Treatment Outcome
- Surgery
- Ribavirin
- Respiratory Syncytial Virus Infections
- Pneumonia, Viral
- Orphan Drug Production
- Infant
- Humans
- Hematopoietic Stem Cell Transplantation
- Health Policy